Cargando…
Selection of iPSCs without mtDNA deletion for autologous cell therapy in a patient with Pearson syndrome
Screening for genetic defects in the cells should be examined for clinical application. The Pearson syndrome (PS) patient harbored nuclear mutations in the POLG and SSBP1 genes, which could induce systemic large-scale mitochondrial genome (mtDNA) deletion. We investigated iPSCs with mtDNA deletions...
Autores principales: | Lee, Yeonmi, Han, Jongsuk, Hwang, Sae-Byeok, Kang, Soon-Suk, Son, Hyeoung-Bin, Jin, Chaeyeon, Kim, Jae Eun, Lee, Beom Hee, Kang, Eunju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471463/ https://www.ncbi.nlm.nih.gov/pubmed/37156631 http://dx.doi.org/10.5483/BMBRep.2022-0204 |
Ejemplares similares
-
mtDNA Deletion in an Iranian Infant with Pearson Marrow Syndrome
por: Arzanian, Mohammad Taghi, et al.
Publicado: (2010) -
De Novo Development of mtDNA Deletion Due to Decreased POLG and SSBP1 Expression in Humans
por: Lee, Yeonmi, et al.
Publicado: (2021) -
Broad Phenotypic Heterogeneity and Multisystem Involvement in Single mtDNA Deletion-associated Pearson Syndrome
por: Finsterer, Josef, et al.
Publicado: (2018) -
Development and characterization of cell models harbouring mtDNA deletions for in vitro study of Pearson syndrome
por: Hernández-Ainsa, Carmen, et al.
Publicado: (2022) -
Elimination of Mutant mtDNA by an Optimized mpTALEN Restores Differentiation Capacities of Heteroplasmic MELAS-iPSCs
por: Yahata, Naoki, et al.
Publicado: (2020)